US 11,730,715 B2
Consumable compositions and methods of producing the same
Erin Holzer, Henderson, CO (US); Peter Barsoom, Henderson, CO (US); and Justin Kirkland, Henderson, CO (US)
Assigned to Nuka Enterprises, Henderson, CO (US)
Filed by Nuka Enterprises, Henderson, CO (US)
Filed on Aug. 6, 2020, as Appl. No. 16/987,103.
Claims priority of provisional application 62/883,619, filed on Aug. 6, 2019.
Prior Publication US 2021/0038560 A1, Feb. 11, 2021
Int. Cl. A61K 31/352 (2006.01); A61K 31/05 (2006.01); A61K 36/185 (2006.01); A61K 36/66 (2006.01); A61K 36/61 (2006.01); A61K 31/522 (2006.01); A61K 9/00 (2006.01); A61K 36/9062 (2006.01); A61K 36/41 (2006.01); A61K 31/198 (2006.01); A61K 36/53 (2006.01); A61K 31/4415 (2006.01); A61K 36/575 (2006.01); A61K 36/81 (2006.01)
CPC A61K 31/352 (2013.01) [A61K 9/0056 (2013.01); A61K 31/05 (2013.01); A61K 31/198 (2013.01); A61K 31/4415 (2013.01); A61K 31/522 (2013.01); A61K 36/185 (2013.01); A61K 36/41 (2013.01); A61K 36/53 (2013.01); A61K 36/575 (2013.01); A61K 36/61 (2013.01); A61K 36/66 (2013.01); A61K 36/81 (2013.01); A61K 36/9062 (2013.01)] 21 Claims
 
1. A composition comprising:
(a) tetrahydrocannabinol (THC) and cannabidiol (CBD) in a balanced ratio, wherein the THC is in an amount of about 1 mg to about 50 mg, the CBD is in an amount of about 1 mg to about 50 mg, and the THC:CBD ratio is 1:1 or 1:5; and
(b) active ingredients comprising one of the following combinations:
(i) theobromine in an amount of 50 mg to 200 mg, sceletium tortuosum in an amount of about 5 mg to about 30 mg, and dihydrohonokiol in an amount of about 2.5 mg to about 25 mg;
(ii) dihydrohonokiol in an amount of about 2.5 mg to about 25 mg and L-theanine in an amount of about 80 mg to about 300 mg;
(iii) theobromine in an amount of about 50 mg to about 300 mg, muira puama in an amount of about 50 mg to about 200 mg, catuaba in an amount of about 25 mg to about 150 mg, damiana in an amount of about 10 mg to about 100 mg, ashwaghanda in an amount of about 1 mg to about 600 mg, and flower pollen in an amount of about 1 mg to about 20 mg;
(iv) alpinia galangal in an amount of about 50 mg to about 300 mg, theobromine in an amount of about 25 mg to about 200 mg, caffeine in an amount of about 30 mg to about 90 mg, and L-theanine in an amount of about 60 mg to about 180 mg; or
(v) alpinia galangal in an amount of about 50 mg to about 500 mg, bacopa in an amount of about 50 mg to about 500 mg, rhodiola in an amount of about 50 mg to about 300 mg, theobromine in an amount of about 25 mg to about 100 mg, caffeine in an amount of about 20 mg to about 60 mg, and L-theanine in an amount of about 40 mg to about 120 mg,
wherein the composition is a tablet, mint, lozenge, pastille, gummy, soft chew, beverage, tincture, lollipop, or chewing gum.